Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Volunteers
In brief
The primary objective of the study is to compare the safety and tolerability of subcutaneous (SC) and intravenous (IV) doses of evinacumab in healthy Japanese and Caucasian subjects.
Key facts
- Study ID
- NCT03146416
- Run by
- Regeneron Pharmaceuticals
- People needed
- 96
- Starts
- 2017-05-16
- Expected to finish
- 2018-06-14
- Last updated by the study team
- 2018-06-25
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- WCCT Global, Inc. — Cypress, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.